Professional background

Dr Javier Pozas is a locum consultant medical oncologist at UCLH with a special interest in GIST, cell therapy and novel immunotherapy agents for the treatment of sarcomas.

He earned his MBBS and completed his speciality training in medical oncology in Madrid, Spain. He further enhanced his clinical experience at Assistance Publique-Hôpitaux de Paris (APHP) in Paris, France, and Peking Union Medical College Hospital in Beijing, China.

He completed his PhD in Madrid and pursued a post-CCT fellowship at the Royal Marsden Hospital, where he continues to contribute as an honorary fellow. In addition to his clinical roles, Javier is a visiting scientist at The Francis Crick Institute.

Research interests

  • Cell therapy 
  • GIST 
  • Immunotherapy 
  • Ultra-rare sarcomas 

Languages spoken

Spanish, French

Publications

  • Pozas J, Thway K, Lindsay D, Fisher C, Smith M, Hayes A, Miah A, Zaidi S, Benson C, Napolitano A, Huang P, Jones RL. Ossifying fibromyxoid tumours: a case series. Eur J Cancer, 2025 Jan 9:217:115229. doi: 10.1016/j.ejca.2025.115229. 
  • Javaid A*, Peres T*, Pozas J*, Thomas J*, Larkin J. Current and emerging treatment options for BRAFV600-mutant melanoma. Expert Rev Anticancer Ther, 2025 Jan 9. doi: 10.1080/14737140.2025.2451722. 
  • Vaz-Salgado MA, Albarrán V, Pozas J, Ferreiro R, Pachón V, Longo F, Rodríguez M, Barretto E, Earl J. Single nucleotide polymorphisms: impact on susceptibility to chemotherapy in patients with colorectal cancer. Future Sci OA, 2024 Dec ;10(1):2428077. doi: 10.1080/20565623.2024.2428077. Epub 2024 Nov 22.  
  • Albarrán V, San Román M, Pozas J, Chamorro J, Rosero D, Guerrero P, Calvo JC, González C, García de Quevedo C, Pérez de Aguado P, Moreno J, Cortés A, Soria A. Adoptive T cell therapy for solid tumors: current landscape and future challenges. Frontiers Immunology, 2024 Mar 14:15:1352805. Doi: 0.3389/fimmu.2024.1352805. eCollection 2024. 
  • Albarrán V, Villamayor ML, Pozas J, Chamorro J, Rosero DI, San Román M, Guerrero P, Pérez de Aguado P, Calvo JC, García de Quevedo C, González C, Vaz MA. Current Landscape of Immunotherapy for Advanced Sarcoma. Cancers (Basel), 2023 Apr 13;15(8):2287. doi: 10.3390/cancers15082287.